長汽(02333.HK)於智利推出「歐拉」品牌
長城汽車(02333.HK)宣布,近日於智利正式推出旗下「歐拉」品牌,而純電動車型「歐拉好貓」亦將於當地上市,成為長汽在智利推出的首款純電動車型,完成智利市場純電及混動的產品佈局。
長汽表示,智利將於2035年全面禁售燃油車,因此車企新能源轉型之路勢在必行,公司已於去年5月在智利推出哈佛JOLION HEV 和哈佛H6 HEV混合動力車型,截止去年底長汽在當地強混HEV市場中銷售排名第二,市佔率達27.4%,預期歐拉好貓的上市將繼續鞏固在智利新能源市場的地位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.